Skip to main content

Advertisement

SpringerLink
Log in

Interleukin-10 promoter polymorphism in patients with rheumatoid arthritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory disease in which interleukin (IL)-10 plays an important role. There are, however, controversial reports that IL-10 promoter polymorphism may be an independent marker of susceptibility and severity of RA. The aim of the present study was to examine the IL-10 promoter polymorphism in patients with RA. We examined 95 patients with rheumatoid arthritis diagnosed according to the criteria of the American College of Rheumatology. Polymerase chain reaction amplification was used for analysis of the promoter polymorphism of the IL-10 gene. In RA patients, the prevalence of genotypes encoding high expression of IL-10 was observed. Nevertheless, there was no association between IL-10 genotypes and age at disease diagnosis, disease activity in a physician’s global assessment, and joint and extra-articular involvement. There was also no correlation between IL-10 polymorphism and disease activity parameters—erythrocyte sedimentation rate, C-reactive protein, number of swollen and tender joints, and duration of morning stiffness. We suggest that IL-10 promoter polymorphism is not a genetic risk factor for RA activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Moore KW, O’Garra A, de Waal Malefyt R, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11:165–190

    CAS  PubMed  Google Scholar 

  2. Chernoff AE, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, Kennedy JS, Rabson AR, Wolff SM, Dinarello CA (1995) A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol 154:5492–5499

    CAS  PubMed  Google Scholar 

  3. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1–8

    CAS  Google Scholar 

  4. Hoffmann SC, Stanley EM, Darrin Cox E, Craighead N, DiMercurio BS, Koziol DE, Harlan DM, Kirk AD, Blair PJ (2001) Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation 72:1444–1450

    CAS  PubMed  Google Scholar 

  5. Prevoo ML, van ’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48

    CAS  PubMed  Google Scholar 

  6. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R (1993) The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 36:729–740

    CAS  PubMed  Google Scholar 

  7. Lahiri DK, Bye S, Nurnberger JI Jr (1992) A non-organic and non-enzymatic extraction method gives higher yields of genomic DNA from whole-blood samples that do nine other methods tested. J Biochem Biophys Methods 25:193–205

    CAS  PubMed  Google Scholar 

  8. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV (1997) An investigation of polymorphism in the Interleukin-10 gene promoter. Eur J Immunogenet 24:1–8

    CAS  Google Scholar 

  9. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE (1999) Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 30:526–530

    CAS  PubMed  Google Scholar 

  10. Walmsley M, Katsikis PD, Abney E, Parry S, Williams RO, Maini RN, Feldmann M (1996) Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum 39:495–503

    CAS  PubMed  Google Scholar 

  11. Verhoef CM, van Roon JA, Vianen ME, Lafeber FP, Bijlsma JW (1999) The immune suppressive effect of dexamethasone in rheumatoid arthritis is accompanied by upregulation of interleukin 10 and by differential changes in interferon gamma and interleukin 4 production. Ann Rheum Dis 58:49–54

    CAS  PubMed  Google Scholar 

  12. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M (1994) Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 179:1517–1527

    CAS  PubMed  Google Scholar 

  13. Joosten LA, Helsen MM, Saxne T, Heinegard D, van de Putte LB, van den Berg WB (1999) Synergistic protection against cartilage destruction by low dose prednisolone and interleukin-10 in established murine collagen arthritis. Inflamm Res 48:48–55

    CAS  PubMed  Google Scholar 

  14. Hajeer AH, Lazarus M, Turner D, Mageed RA, Vencovsky J, Sinnott P, Hutchinson IV, Ollier WE (1998) IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scand J Rheumatol 27:142–145

    CAS  PubMed  Google Scholar 

  15. Coakley G, Mok CC, Hajeer AH, Ollier WE, Turner D, Sinnott PJ, Hutchinson IV, Panayi GS, Lanchbury JS (1998) Interleukin-10 promoter polymorphisms in rheumatoid arthritis and Felty’s syndrome. Br J Rheumatol 37:988–991

    CAS  PubMed  Google Scholar 

  16. Cantagrel A, Navaux F, Loubet-Lescoulie P, Nourhashemi F, Enault G, Abbal M, Constantin A, Laroche M, Mazieres B (1999) Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 42:1093–1100

    CAS  PubMed  Google Scholar 

  17. Eskdale J, McNicholl J, Wordsworth P, Jonas B, Huizinga T, Field M, Gallagher G (1998) Interleukin-10 microsatellite polymorphisms and IL-10 locus alleles in rheumatoid arthritis susceptibility. Lancet 352:1282–1283

    CAS  PubMed  Google Scholar 

  18. MacKay K, Milicic A, Lee D, Tikly M, Laval S, Shatford J, Wordsworth P (2003) Rheumatoid arthritis susceptibility and interleukin 10: a study of two ethnically diverse populations. Rheumatology (Oxford) 42:149–153

    CAS  Google Scholar 

  19. Padyukov L, Hytonen AM, Smolnikova M, Hahn-Zoric M, Nilsson N, Hanson LA, Tarkowski A, Klareskog L (2004) Polymorphism in promoter region of IL10 gene is associated with rheumatoid arthritis in women. J Rheumatol 31:422–425

    CAS  PubMed  Google Scholar 

  20. Lard LR, van Gaalen FA, Schonkeren JJ, Pieterman EJ, Stoeken G, Vos K, Nelissen RG, Westendorp RG, Hoeben RC, Breedveld FC, Toes RE, Huizinga TW (2003) Association of the −2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis. Arthritis Rheum 48:1841–1848

    CAS  PubMed  Google Scholar 

  21. Poli F, Nocco A, Berra S, Scalamogna M, Taioli E, Longhi E, Sirchia G (2002) Allele frequencies of polymorphisms of TNFα, IL-6, IL-10 and IFNγ in an Italian Caucasian population. Eur J Immunogenet 29:237–240

    Article  CAS  PubMed  Google Scholar 

  22. Reynard MP, Turner D, Navarret CV (2000) Allele frequencies of polymorphism of the TNFα, IL-10, INFγ and IL-2 genes in North European Caucasoid group from the UK. Eur J Immunogenet 27:241–249

    CAS  PubMed  Google Scholar 

  23. Huizinga TW, Keijsers V, Yanni G, Hall M, Ramage W, Lanchbury J, Pitzalis C, Drossaers-Bakker WK, Westendorp RG, Breedveld FC, Panayi G, Verweij CL (2000) Are differences in interleukin 10 production associated with joint damage? Rheumatology (Oxford) 39:1180–1188

    CAS  Google Scholar 

  24. Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu DH, Kastelein R, Moore KW, Banchereau J (1992) Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A 89:1890–1893

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacokinetics and Therapeutic Drug Monitoring, Pomeranian Merical University, 70-111, Szczecin, ul. Powst. Wlkp. 72, Poland

    Andrzej Pawlik, Mateusz Kurzawski, Barbara Gawronska Szklarz & Marek Drozdzik

  2. Department of Rheumatology, Pomeranian Medical University, 70-111, Szczecin, ul. Powst.Wlkp. 72, Poland

    Magdalena Herczynska

Authors
  1. Andrzej Pawlik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mateusz Kurzawski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Barbara Gawronska Szklarz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Magdalena Herczynska
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marek Drozdzik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrzej Pawlik.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pawlik, A., Kurzawski, M., Szklarz, B.G. et al. Interleukin-10 promoter polymorphism in patients with rheumatoid arthritis. Clin Rheumatol 24, 480–484 (2005). https://doi.org/10.1007/s10067-004-1066-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-004-1066-5

Keywords

Search

Navigation